Shao-Lee Lin - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Shao-Lee Lin has filed 4 SEC Form 4 filings across 1 company in the last 90 days - buying. Lifetime open-market purchases: $1000K.
Profile
Shao-Lee Lin is a corporate insider at Cue Biopharma, Inc. (CUE). Lin has reported 3 insider filings with the SEC since 2026. The most recent filing was in July 2026.
| Role | Chief Executive Officer, Director |
|---|---|
| Notability | 20/100 |
Board memberships
- Cue Biopharma, Inc.
Awards & honors
- Listed as insider at Cue Biopharma, Inc. in SEC filings (as of 2026-05-07)
Trading Pattern
InsiderAlpha's records for Shao-Lee Lin go back to 2026: 4 primary Form 4 filings, an average of 4.0 per year. The typical open-market purchase is $500K (2 buys totaling $1000K). The largest single buy on record is $1000K of CUE in 2026. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Shao-Lee Lin has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Chief Executive Officer, Director at Cue Biopharma, Inc. (CUE) - 1 filing, 2026
- Chief Executive Officer at Cue Biopharma, Inc. (CUE) - 2 filings, 2026
- CHIEF EXECUTIVE OFFICER at Cue Biopharma, Inc. (CUE) - 1 filing, 2026
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-10 | CUE | Cue Biopharma, Inc. | A - Grant or award | 327.5K | $0.00 | |
| 2026-05-07 | CUE | Cue Biopharma, Inc. | A - Grant or award | 327.5K | $0.00 |
Companies - Last 90 Days
- Cue Biopharma, Inc. (CUE) - 4 filings, last 2026-07-30
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Shao-Lee Lin has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Pasha Sarraf - $100K of CUE open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Thomas J. Shaw
- Silver Point Capital L.P.
- SilverBay Capital Management LLC
- Michael Simanovsky
- Bob R. Simpson
- Ranbir Singh
- Ross Jeffery Sklar
- Barry Sloane
Frequently Asked Questions
Who is Shao-Lee Lin?
Shao-Lee Lin is a corporate insider at Cue Biopharma, Inc. (CUE). Lin has reported 3 insider filings with the SEC since 2026. The most recent filing was in July 2026.…
How many SEC Form 4 filings has Shao-Lee Lin submitted recently?
4 primary Form 4 filings in the last 90 days, covering 1 company.
Has Shao-Lee Lin been buying or selling stock?
Recorded transactions: 2 open-market purchases ($1000K) and 0 open-market sales across all tracked filings.
Where can I see all of Shao-Lee Lin's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Shao-Lee Lin profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.